Periprosthetic knee fractures in an elderly population: open reduction and internal fixation vs distal femur megaprostheses.
ORIF
knee
megaprosthesis
periprosthetic
Journal
Orthopedic reviews
ISSN: 2035-8164
Titre abrégé: Orthop Rev (Pavia)
Pays: United States
ID NLM: 101524779
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
10
2021
accepted:
04
01
2022
entrez:
1
7
2022
pubmed:
2
7
2022
medline:
2
7
2022
Statut:
epublish
Résumé
The incidence of periprosthetic fractures of distal femur (PPDFFx) after primary total knee arthroplasties is described around 0.3% and 2.5% and it is increasing as the number of patients with total knee arthroplasty continues to arise. surgical options treatments for PPDFFx include fixation in the form of eather Open reduction and internal fixation (ORIF), or retrograde intramedullary nailing (RIMN), or conventional (non locked) plating, or locked plating such as the Less Invasive Stabilization System (LISS), or dynamic condylar screws. In recent years, however, the use of megaprostheses has been increasing. Patients with periprosthetic fractures of distal femur after primary total knee arthroplasties treated with ORIF or with the use of Distal femur replacement (DFR) were retrospectively analyzed in this to evaluate differences in intra-operative blood loss, need of blood trasfusion, weight bearing, range of motion, rate of complications, rate of revision surgery and functional outcome according Oxford Knee Score between two groups. Treatment of Periprosthetic distal femur fracture remains controversial. While ORIF seems to guarantee less percentage of complications and reoperation rate, those treated with megaprosthesis seem to gain better range of motion in a very short post-operative time. In the future it will be necessary to investigate with greater numbers possible advantages and disadvantages of the various treatments in periprosthetic distal femur fractures.
Identifiants
pubmed: 35774922
doi: 10.52965/001c.33772
pii: 33772
pmc: PMC9239368
doi:
Types de publication
Journal Article
Langues
eng
Pagination
33772Déclaration de conflit d'intérêts
The authors declare no potential conflict of interest.
Références
Arch Orthop Trauma Surg. 2021 Jun;141(6):997-1006
pubmed: 33743062
JBJS Rev. 2020 Sep;8(9):e2000003
pubmed: 33151645
J Am Acad Orthop Surg. 2004 Jan-Feb;12(1):12-20
pubmed: 14753793
Injury. 2020 Aug;51 Suppl 3:S17-S22
pubmed: 31526601
Orthop Rev (Pavia). 2020 Jun 25;12(Suppl 1):8662
pubmed: 32913597
Arch Orthop Trauma Surg. 2021 Feb;141(2):207-214
pubmed: 33128096
J Biol Regul Homeost Agents. 2019 Nov-Dec;34(4 Suppl. 3):275-278. Congress of the Italian Orthopaedic Research Society
pubmed: 33261289
Clin Orthop Relat Res. 1997 Dec;(345):113-24
pubmed: 9418628
Orthop Rev (Pavia). 2020 Jun 26;12(Suppl 1):8689
pubmed: 32913616
J Orthop Trauma. 2014 May;28(5):307-12
pubmed: 24149447
Injury. 2022 Mar;53(3):1241-1246
pubmed: 34602244
J Orthop Trauma. 2022 Jan 1;36(1):1-6
pubmed: 34001801
J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6 Suppl. 1):45-49
pubmed: 30644281
Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):252-257
pubmed: 30977892
Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):19-25
pubmed: 30977867
J Trauma. 2010 Sep;69(3):670-6
pubmed: 20838138
Geriatr Orthop Surg Rehabil. 2020 Jul 19;11:2151459320939550
pubmed: 32733772
J Biol Regul Homeost Agents. ;31(4 suppl 1):51-60
pubmed: 29185296
Wien Klin Wochenschr. 2021 Jun;133(11-12):550-559
pubmed: 33847836